Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,370 | 46 | 80.8% |
| Gift | $265.20 | 1 | 15.6% |
| Education | $61.20 | 1 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Veloxis Pharmaceuticals, Inc. | $373.25 | 13 | $0 (2024) |
| NxThera, Inc. | $269.76 | 2 | $0 (2018) |
| AbbVie, Inc. | $267.31 | 4 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $217.53 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $142.41 | 3 | $0 (2024) |
| Kyowa Kirin, Inc. | $86.88 | 3 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $79.05 | 2 | $0 (2019) |
| Alnylam Pharmaceuticals Inc. | $56.76 | 2 | $0 (2023) |
| Janssen Biotech, Inc. | $40.39 | 3 | $0 (2019) |
| Blue Earth Diagnostics Limited | $32.00 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $356.65 | 11 | E.R. Squibb & Sons, L.L.C. ($126.05) |
| 2023 | $260.32 | 9 | Veloxis Pharmaceuticals, Inc. ($100.08) |
| 2022 | $73.07 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($48.73) |
| 2021 | $18.74 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($18.74) |
| 2020 | $184.51 | 6 | Veloxis Pharmaceuticals, Inc. ($160.35) |
| 2019 | $188.20 | 8 | Otsuka America Pharmaceutical, Inc. ($61.20) |
| 2018 | $275.17 | 5 | AbbVie, Inc. ($254.80) |
| 2017 | $339.43 | 5 | NxThera, Inc. ($265.20) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | NULOJIX (Biological) | Food and Beverage | Cash or cash equivalent | $15.72 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: TRANSPLANTATION | ||||||
| 09/04/2024 | E.R. Squibb & Sons, L.L.C. | NULOJIX (Biological) | Food and Beverage | Cash or cash equivalent | $110.33 | General |
| Category: Immunology | ||||||
| 08/13/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $33.71 | General |
| Category: TRANSPLANTATION | ||||||
| 07/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $29.99 | General |
| Category: IMMUNOLOGY | ||||||
| 05/31/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $28.92 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 04/30/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug) | Food and Beverage | In-kind items and services | $30.84 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $29.44 | General |
| Category: IMMUNOLOGY | ||||||
| 04/16/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $28.16 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 04/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: IMMUNOLOGY | ||||||
| 01/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Oncology | ||||||
| 12/18/2023 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 12/13/2023 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $29.76 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2023 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $33.82 | General |
| Category: TRANSPLANTATION | ||||||
| 09/12/2023 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2023 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $33.72 | General |
| Category: TRANSPLANTATION | ||||||
| 06/17/2023 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $32.54 | General |
| Category: TRANSPLANTATION | ||||||
| 06/16/2023 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Food and Beverage | In-kind items and services | $29.57 | General |
| Category: Genetic Disease | ||||||
| 02/10/2023 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Food and Beverage | In-kind items and services | $27.19 | General |
| Category: Genetic Disease | ||||||
| 01/25/2023 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: IMMUNOLOGY | ||||||
| 09/09/2022 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Nephrology | ||||||
| 08/12/2022 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: IMMUNOLOGY | ||||||
| 03/01/2022 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $30.21 | General |
| Category: IMMUNOLOGY | ||||||
| 10/12/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $18.74 | General |
| 11/11/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | Cash or cash equivalent | $26.53 | General |
| Category: Immunosuppressant | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,045 | 1,543 | $924,590 | $318,248 |
| 2022 | 15 | 907 | 1,339 | $719,130 | $257,779 |
| 2021 | 18 | 1,216 | 2,182 | $789,885 | $290,942 |
| 2020 | 16 | 1,220 | 2,163 | $664,385 | $232,640 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 16 | 18 | $2,880 | $1,047 | 36.4% |
| 76775 | Ultrasound behind abdominal cavity, limited | Office | 2021 | 14 | 20 | $6,900 | $1,017 | 14.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 14 | 16 | $2,560 | $996.80 | 38.9% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2021 | 12 | 12 | $2,400 | $443.64 | 18.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 316 | 878 | $220,800 | $78,815 | 35.7% |
| 50360 | Transplantation of donor kidney | Facility | 2020 | 16 | 16 | $83,200 | $33,794 | 40.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 96 | 134 | $66,800 | $23,527 | 35.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 163 | 288 | $43,800 | $16,042 | 36.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 110 | 113 | $35,100 | $14,064 | 40.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 69 | 219 | $32,850 | $13,721 | 41.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 144 | 165 | $41,250 | $10,919 | 26.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 57 | 57 | $25,650 | $9,700 | 37.8% |
| 50605 | Insertion of stent in urinary duct (ureter) | Facility | 2020 | 16 | 16 | $36,800 | $6,960 | 18.9% |
| 76776 | Ultrasound of transplanted kidney | Office | 2020 | 44 | 45 | $18,675 | $6,570 | 35.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 29 | 53 | $10,600 | $4,793 | 45.2% |
| 76856 | Ultrasound of pelvis | Office | 2020 | 26 | 27 | $9,450 | $2,674 | 28.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 17 | 17 | $5,950 | $2,258 | 37.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 23 | 23 | $6,900 | $2,201 | 31.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 20 | 20 | $7,000 | $2,180 | 31.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 18 | 29 | $4,450 | $1,273 | 28.6% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2020 | 12 | 12 | $7,200 | $977.76 | 13.6% |
| 76857 | Ultrasound of pelvis | Office | 2020 | 18 | 21 | $5,250 | $917.08 | 17.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 13 | 14 | $1,540 | $896.14 | 58.2% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 13 | 16 | $1,120 | $357.44 | 31.9% |
About Dr. Robert Naraghi, M.D
Dr. Robert Naraghi, M.D is a Specialist healthcare provider based in Orange, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306950043.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Naraghi, M.D has received a total of $1,696 in payments from pharmaceutical and medical device companies, with $356.65 received in 2024. These payments were reported across 48 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,370).
As a Medicare-enrolled provider, Naraghi has provided services to 4,388 Medicare beneficiaries, totaling 7,227 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Urology
- Location Orange, CA
- Active Since 08/19/2006
- Last Updated 06/25/2025
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1306950043
Products in Payments
- Rezum (Device) $269.76
- Mavyret (Drug) $267.31
- LIVTENCITY (Drug) $198.79
- Envarsus (Drug) $198.55
- ENVARSUS (Drug) $147.69
- NULOJIX (Biological) $126.05
- Crysvita (Drug) $86.88
- SAMSCA (Drug) $79.05
- OXLUMO (Drug) $56.76
- Erleada (Drug) $40.39
- Axumin (Drug) $32.00
- PREVYMIS (Drug) $30.84
- TARPEYO (Drug) $24.34
- LOKELMA (Drug) $24.16
- BOTOX (Drug) $19.54
- Cologuard Collection Kit (Device) $18.69
- OPDIVO (Biological) $16.36
- Envarsus XR (SP) (Drug) $15.81
- ZORTRESS (Drug) $13.18
- Envarsus XR (Drug) $11.20
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Orange
Andrew Cassidenti, M.d, M.D
Specialist — Payments: $83,590
Dr. Steve Mora, M.d, M.D
Specialist — Payments: $54,129
Dr. Brian Palafox, M.d, M.D
Specialist — Payments: $53,229
Dr. Samuel Rosenfeld, M.d, M.D
Specialist — Payments: $47,823
Dr. Thomas Kim, M.d, M.D
Specialist — Payments: $47,716
Gerald Alexander, M.d, M.D
Specialist — Payments: $45,760